← Back to Search

Implementation Strategies for Cancer Screening

N/A
Waitlist Available
Led By Karen M Emmons, PhD
Research Sponsored by Harvard School of Public Health (HSPH)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial looks at how to make one medical intervention easier to use in practice.

Who is the study for?
This trial is for individuals over the age of 18 who work at participating Community Health Centers. It's focused on improving how these centers carry out cancer screening and follow-up care.Check my eligibility
What is being tested?
The study is looking into practice-level implementation strategies to see how they can help health centers better implement interventions for breast and colorectal cancer screenings.See study design
What are the potential side effects?
Since this trial involves implementation strategies rather than medical treatments, it does not have side effects in the traditional sense associated with medications or procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of open orders for FIT screening
Number of open orders for mammography screening
Secondary outcome measures
Acceptability of Implementation Strategies
Appropriateness of Implementation Strategies
Feasibility of Implementation Strategies
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: All Pilot SitesExperimental Treatment1 Intervention
All community health centers participating in the study will implement the new population health management tools utilizing tailored implementation strategies

Find a Location

Who is running the clinical trial?

Harvard School of Public Health (HSPH)Lead Sponsor
272 Previous Clinical Trials
16,305,004 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,580 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,145 Total Patients Enrolled
3 Trials studying Breast Cancer Screening
102,227 Patients Enrolled for Breast Cancer Screening

Media Library

All Pilot Sites Clinical Trial Eligibility Overview. Trial Name: NCT05756725 — N/A
Breast Cancer Screening Research Study Groups: All Pilot Sites
Breast Cancer Screening Clinical Trial 2023: All Pilot Sites Highlights & Side Effects. Trial Name: NCT05756725 — N/A
All Pilot Sites 2023 Treatment Timeline for Medical Study. Trial Name: NCT05756725 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants accepted for this research program?

"As indicated on the clinicaltrials.gov platform, this trial is not presently recruiting candidates. It was initially posted in July of 2023 and last updated in June of 2023; however, there are 923 other studies that are currently enrolling patients."

Answered by AI

What key objectives is the clinical trial seeking to accomplish?

"This 4-month trial aims to quantify the number of mammography screenings that are ordered. Additional objectives include gauging implementation strategies by conducting qualitative interviews, calculating time to diagnostic resolution for those with abnormal FIT tests from electronic health records, and assessing acceptability of implementation strategies also through interviewer feedback."

Answered by AI
~5 spots leftby Apr 2025